Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition
GlobeNewswire, Inc.
NEW YORK and TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) (“Tilray”), a global leader in medical cannabis, today announced the acquisition of HelloMD Corporation, a digital healthcare and patient...
BrewDog and Tilray Beer Add Canada to The World's Biggest Bar Tab as Canada Advances to the Next Round
GlobeNewswire, Inc.
Canada, England or the U.S. to the final?
Saskatchewan Protecting Health IT Infrastructure With $43M Investment
Government of Saskatchewan
CANADA, June 29 - Released on June 29, 2026 eHealth Saskatchewan will invest $43.6 million in information technology (IT) capital and operational purchases in the coming year.
Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
GlobeNewswire, Inc.
Austin, TX, USA, June 29, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Hematologic Malignancies Testing Market Size, Trends and Insights By Product (Kits, Services), By Platform (Next-Generation...
New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome
GlobeNewswire, Inc.
Clinically meaningful improvements in skin symptoms reported as early as week 4 and sustained over the 48-week study period Data presented at the 6th World Congress of Cutaneous Lymphomas meeting in Montreal, Canada PRINCETON, N.J., June 29, 2026...
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
GlobeNewswire, Inc.
Optimi’s 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression.
Rogers Giving Away 500 Blue Jays Tickets to Coveted Canada Day Game
GlobeNewswire, Inc.
TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- To celebrate Canada Day and the Blue Jays 50th season, Rogers is giving away 500 free tickets to one of the season’s most sought-after games.
GuideAI Health Corp. to Begin Trading on Cboe Canada Under the Symbol "GDAI"
GlobeNewswire, Inc.
BOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. ("GuideAI" or the "Company") (Cboe CA: GDAI) is pleased to report that the Company has received final approval to list its common shares (the "Shares") on Cboe Canada Inc. ("Cboe...
[Latest] Global Neonatal Infant Care Market Size/Share Worth USD 8.94 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire, Inc.
Austin, TX, USA, June 29, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Neonatal Infant Care Market Size, Trends and Insights By Product Type (Thermoregulation Devices (Incubators, Radiant Warmers,...
Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress
GlobeNewswire, Inc.
June 29, 2026 Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Biodexa” or “the Company”), a clinical stage biopharmaceutical company...
Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength
GlobeNewswire, Inc.
Vancouver, Canada, June 29, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation,...
Court Approval of a Restructuring Transaction Allowing Continuation of Uninterrupted Operations
GlobeNewswire, Inc.
MONTREAL, July 03, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health” or the “Company”) announces that, in connection with the proceedings initiated on June 23, 2026 by the Royal Bank of Canada (the “Applicant”)...
Dr. Mariusz Sapijaszko elected President of the Canadian Dermatology Association
GlobeNewswire, Inc.
OTTAWA, Ontario, June 29, 2026 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association (CDA) is pleased to announce the appointment of Dr. Mariusz Sapijaszko as CDA President, effective June 25, 2026. Dr. Mariusz Sapijaszko is an Edmonton-based...
Bavarian Nordic Receives Health Canada Approval for Chikungunya Vaccine
GlobeNewswire, Inc.
COPENHAGEN, Denmark, June 29, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Health Canada has approved VIMKUNYA® (recombinant, adsorbed) for immunization to prevent disease caused by chikungunya virus infection for individuals 12...
Next Hydrogen, a Canadian Company, Expands Further into the Fusion Market Through Strategic Collaboration with Fusion Fuel Cycles Inc.
GlobeNewswire, Inc.
MISSISSAUGA, Ontario, June 29, 2026 (GLOBE NEWSWIRE) -- Next Hydrogen Solutions Inc. (“Next Hydrogen” or the “Company”) (TSXV:NXH) is pleased to announce a collaboration agreement with Fusion Fuel Cycles Inc. (“FFC”) to demonstrate purpose-built...
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
GlobeNewswire, Inc.
MDNA11, as a single agent or in combination with pembrolizumab, continues to demonstrate compelling anti-tumor activity in patients with advanced or metastatic cutaneous melanoma, endometrial cancer and gastrointestinal cancers unresponsive to...
BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia
GlobeNewswire, Inc.
- Phase 3 PROPEL 3 data published today in NEJM were simultaneously presented at ICCBH in a late-breaking oral presentation; presentation includes new arm span Z-score data showing a statistically significant improvement versus placebo (LS mean...
Canadian Red Cross launches appeal to support people impacted by the earthquakes in Venezuela
GlobeNewswire, Inc.
OTTAWA, Ontario, June 25, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is working to support those impacted by the earthquakes in Venezuela and has launched the 2026 Venezuela Earthquakes Appeal.
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
GlobeNewswire, Inc.
HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has...
Canadian Red Cross and Walmart Canada launch annual giving campaign
GlobeNewswire, Inc.
OTTAWA, June 25, 2026 (GLOBE NEWSWIRE) -- As Canadians face an active start to the wildfire season and communities continue to recover from recent floods, the Canadian Red Cross and Walmart Canada are launching their annual giving campaign to...
Sign up for:
Canadian Health Industry News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.